Search
4D Molecular Therapeutics Inc
FDMTAdd to Watchlist
13.000USD
+0.310+2.44%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
679.59MMarket Cap
LossP/E TTM
4D Molecular Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
85.21M
230194.59%
EPS(YoY)
-2.42
18.90%
Analyst Rating
BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total revenue reached 85.21M, with a year-on-year change of 230194.59.
What are the current assets of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its current assets were 413.13M, with a year-on-year change of -5.01.
What are the total assets of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total assets of 4D Molecular Therapeutics Inc were 566.71M, with a year-on-year change of 1.13.
What are the total liabilities of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total liabilities of 4D Molecular Therapeutics Inc were 61.05M, with a year-on-year change of 22.64.
What is the total equity of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total equity of 4D Molecular Therapeutics Inc was 505.66M, with a year-on-year change of -0.97.
What is the net investment of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net investment of 4D Molecular Therapeutics Inc was -92.97M, with a year-on-year change of 69.26.
What is the net financing of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net financing of 4D Molecular Therapeutics Inc was 112.96M, with a year-on-year change of -66.51.
What is the Earnings Per Share (EPS) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.42, with a year-on-year change of 18.90.
What is the net margin of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net profit margin was -164.43, with a year-on-year change of 99.96.
What is the Return on Equity (ROE) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -27.57, with a year-on-year change of 29.86.
What is the Return on Assets (ROA) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -24.86, with a year-on-year change of 30.43.
What is the operating profit of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its operating profit was -159.55M, with a year-on-year change of 15.06.